Colon Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colon Cancer, including details on causes, treatment, symptoms.

Volume 2 (2005), Issue 6 (June)

1. Increased cyclooxygenase-2 expression in duodenal compared with colonic tissues in familial adenomatous polyposis and relationship to the -765G -> C COX-2 polymorphism.
   Clin Cancer Res, 11(11): 4090-6. [Abstract] [Full-text]
2. A secreted form of ADAM9 promotes carcinoma invasion through tumor-stromal interactions.
   Cancer Res, 65(11): 4728-38. [Abstract] [Full-text]
3. Hypersialylation of beta1 integrins, observed in colon adenocarcinoma, may contribute to cancer progression by up-regulating cell motility.
   Cancer Res, 65(11): 4645-52. [Abstract] [Full-text]
4. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
   J Endocrinol, 185(3): 577-92. [Abstract] [Full-text]
5. Genome-wide expression analysis of therapy-resistant tumors reveals SPARC as a novel target for cancer therapy.
   J Clin Invest, 115(6): 1492-502. [Abstract] [Full-text]
6. Oncogenic Ras increases sensitivity of colon cancer cells to 5-FU-induced apoptosis.
   Oncogene, 24(24): 3932-41. [Abstract] [Full-text]
7. CpG island promoter hypermethylation of a novel Ras-effector gene RASSF2A is an early event in colon carcinogenesis and correlates inversely with K-ras mutations.
   Oncogene, 24(24): 3987-94. [Abstract] [Full-text]
8. CHFR promoter hypermethylation in colon cancer correlates with the microsatellite instability phenotype.
   Carcinogenesis, 26(6): 1152-6. [Abstract] [Full-text]
9. Butyrate may enhance toxicological defence in primary, adenoma and tumor human colon cells by favourably modulating expression of glutathione S-transferases genes, an approach in nutrigenomics.
   Carcinogenesis, 26(6): 1064-76. [Abstract] [Full-text]
10. Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells.
    Photochem Photobiol, 81(2): 306-13. [Abstract] [Full-text]
11. Adjuvant therapy with edrecolomab versus observation in stage II colon cancer: a multicenter randomized phase III study.
    Onkologie, 28(6): 347-50. [Abstract] [Full-text]
12. The ileo neo rectal anastomosis (INRA) in patients with familial adenomatous polyposis: clinical results at two years.
    Colorectal Dis, 7(4): 354-9. [Abstract] [Full-text]
13. Is prophylactic colectomy indicated in patients with MYH-associated polyposis?
    Colorectal Dis, 7(4): 327-31. [Abstract] [Full-text]
14. Operative salvage for locoregional recurrent colon cancer after curative resection: an analysis of 100 cases.
    Dis Colon Rectum, 48(5): 897-909. [Abstract] [Full-text]
15. Sensitization of colon cancer cell lines to butyrate-mediated proliferation inhibition by combined application of indomethacin and nordihydroguaiaretic acid.
    Cancer Detect Prev, 29(3): 276-85. [Abstract] [Full-text]
16. Effects of oral 5-fluorouracil drugs on hepatic fat content in patients with colon cancer.
    Acad Radiol, 12(6): 722-7. [Abstract] [Full-text]
17. HERG K+ channel expression-related chemosensitivity in cancer cells and its modulation by erythromycin.
    Cancer Chemother Pharmacol, 56(2): 212-20. [Abstract] [Full-text]
18. Gene-directed enzyme prodrug therapy with carboxylesterase enhances the anticancer efficacy of the conditionally replicating adenovirus AdDelta24.
    Gene Ther, 12(12): 1011-8. [Abstract] [Full-text]
19. A unique gene having homology with the kinesin family member 18A encodes a tumour-associated antigen recognised by cytotoxic T lymphocytes from HLA-A2+ colon cancer patients.
    Eur J Cancer, 41(9): 1323-30. [Abstract] [Full-text]
20. Desmoid tumors and deep fibromatoses.
    Hematol Oncol Clin North Am, 19(3): 565-71, vii-viii. [Abstract] [Full-text]
21. Combined electric field and ultrasound therapy as a novel anti-tumour treatment.
    Eur J Cancer, 41(9): 1339-48. [Abstract] [Full-text]
22. Genotoxicity of 4-hydroxy-2-nonenal in human colon tumor cells is associated with cellular levels of glutathione and the modulation of glutathione S-transferase A4 expression by butyrate.
    Toxicol Sci, 86(1): 27-35. [Abstract] [Full-text]
23. Project PREVENT: a randomized trial to reduce multiple behavioral risk factors for colon cancer.
    Cancer Epidemiol Biomarkers Prev, 14(6): 1453-9. [Abstract] [Full-text]
24. Abdominal obesity, insulin resistance, and colon carcinogenesis are increased in mutant mice lacking gastrin gene expression.
    Cancer, 103(12): 2643-53. [Abstract] [Full-text]
25. Zinc finger protein overexpressed in colon carcinoma interacts with the telomeric protein hRap1.
    J Cell Biochem, 95(4): 763-8. [Abstract] [Full-text]
26. ERbeta is a potent inhibitor of cell proliferation in the HCT8 human colon cancer cell line through regulation of cell cycle components.
    Endocr Relat Cancer, 12(2): 455-69. [Abstract] [Full-text]
27. In vivo imaging of colitis and colon cancer development in mice using high resolution chromoendoscopy.
    Gut, 54(7): 950-4. [Abstract] [Full-text]
28. Importance of N- and C-terminal regions of gastrin-Gly for preferential binding to high and low affinity gastrin-Gly receptors.
    Peptides, 26(7): 1207-12. [Abstract] [Full-text]
29. Colonic adenocarcinoma and stones in an Indiana pouch.
    Int J Urol, 12(4): 412-3. [Abstract] [Full-text]
30. Laparoscopic environmental changes during surgery enhance the invasive potential of tumours.
    Tumour Biol, 26(2): 94-102. [Abstract] [Full-text]
31. Transformation by oncogenic RAS sensitizes human colon cells to TRAIL-induced apoptosis by up-regulating death receptor 4 and death receptor 5 through a MEK-dependent pathway.
    J Biol Chem, 280(24): 22856-67. [Abstract] [Full-text]
32. Differential expression of proteins in response to ceramide-mediated stress signal in colon cancer cells by 2-D gel electrophoresis and MALDI-TOF-MS.
    J Proteome Res, 4(3): 870-80. [Abstract] [Full-text]
33. Gene expression signatures for colorectal cancer microsatellite status and HNPCC.
    Br J Cancer, 92(12): 2240-8. [Abstract] [Full-text]
34. Expression of cell survival/death genes: Bcl-2 and Bax at the rate of colon cancer prognosis.
    Biochim Biophys Acta, 1741(1): 25-9. [Abstract] [Full-text]
35. Metallothionein crypt-restricted immunopositivity indices (MTCRII) correlate with aberrant crypt foci (ACF) in mouse colon.
    Br J Cancer, 92(12): 2160-5. [Abstract] [Full-text]
36. LPA2 receptor mediates mitogenic signals in human colon cancer cells.
    Am J Physiol Cell Physiol, 289(1): C2-11. [Abstract] [Full-text]
37. Stability of phosphoprotein as a biological marker of tumor signaling.
    Clin Cancer Res, 11(12): 4338-40. [Abstract] [Full-text]
38. SKI-606, a Src/Abl inhibitor with in vivo activity in colon tumor xenograft models.
    Cancer Res, 65(12): 5358-64. [Abstract] [Full-text]
39. 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone from cigarette smoke stimulates colon cancer growth via beta-adrenoceptors.
    Cancer Res, 65(12): 5272-7. [Abstract] [Full-text]
40. Heat shock protein 70 surface-positive tumor exosomes stimulate migratory and cytolytic activity of natural killer cells.
    Cancer Res, 65(12): 5238-47. [Abstract] [Full-text]
41. A 10-year outcomes evaluation of mucinous and signet-ring cell carcinoma of the colon and rectum.
    Dis Colon Rectum, 48(6): 1161-8. [Abstract] [Full-text]
42. Connexin43 is overexpressed in Apc(Min/+)-mice adenomas and colocalises with COX-2 in myofibroblasts.
    Int J Cancer, 116(3): 351-8. [Abstract] [Full-text]
43. 2-Cyano-3,12-dioxoolean-1,9-dien-28-oic acid and related compounds inhibit growth of colon cancer cells through peroxisome proliferator-activated receptor gamma-dependent and -independent pathways.
    Mol Pharmacol, 68(1): 119-28. [Abstract] [Full-text]
44. Curative resection of T1 colorectal carcinoma: risk of lymph node metastasis and long-term prognosis.
    Dis Colon Rectum, 48(6): 1182-92. [Abstract] [Full-text]
45. Partial downregulation of MAD1 causes spindle checkpoint inactivation and aneuploidy, but does not confer resistance towards taxol.
    Oncogene, 24(26): 4301-10. [Abstract] [Full-text]
46. Tangutorine induces p21 expression and abnormal mitosis in human colon cancer HT-29 cells.
    Biochem Pharmacol, 70(2): 287-99. [Abstract] [Full-text]
47. Radiology-Pathology Conference: carcinosarcoma of the colon.
    Clin Imaging, 29(4): 259-62. [Abstract] [Full-text]
48. Eosinophilic cellulitis (Wells' syndrome) associated with colon carcinoma.
    J Dtsch Dermatol Ges, 3(7): 530-1. [Abstract] [Full-text]
49. Chemopreventive properties of apple procyanidins on human colon cancer-derived metastatic SW620 cells and in a rat model of colon carcinogenesis.
    Carcinogenesis, 26(7): 1291-5. [Abstract] [Full-text]
50. Autofluorescence characterisation of isolated whole crypts and primary cultured human epithelial cells from normal, hyperplastic, and adenomatous colonic mucosa.
    J Clin Pathol, 58(7): 766-74. [Abstract] [Full-text]
51. Primary signet-ring cell carcinoma mimicking segmental Crohn's colitis.
    Dig Liver Dis, 37(7): 537-41. [Abstract] [Full-text]
52. Unicystic ameloblastoma presenting in Gardner's syndrome: a case report.
    Br Dent J, 198(12): 747-8. [Abstract] [Full-text]
53. The utility of capsule endoscopy small bowel surveillance in patients with polyposis.
    Am J Gastroenterol, 100(7): 1498-502. [Abstract] [Full-text]
54. Inhibitory effect of genistein on mouse colon cancer MC-26 cells involved TGF-beta1/Smad pathway.
    Biochem Biophys Res Commun, 333(3): 827-32. [Abstract] [Full-text]
55. Capecitabine as adjuvant treatment for stage III colon cancer.
    N Engl J Med, 352(26): 2696-704. [Abstract] [Full-text]

© 2004-2008 Colon Cancer Research Today. All Rights Reserved.